AVROBIO
$22.549876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$22.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.22 (-0.97%) As of 2:31 PM EST today
-$0.22 (-0.97%) Today
Why Robinhood?
You can buy or sell AVROBIO and other stocks, options, ETFs, and crypto commission-free!
About AVRO
Avrobio, Inc. engages in the development of lentiviral-based gene therapies. It focuses on gene therapy for fabry, gaucher, pompe disease, and cystinosis. Read More These gene therapies, on which the company was founded, were developed by Dr. Jeffrey Medin and Dr. Christopher Paige at the University Health Network. AvroBio launched in 2015, is headed by Co-Founder, President and CEO Geoff Mackay, and is headquartered in Cambridge, MA.
CEO
Employees
49
Headquarters
Cambridge, Massachusetts
Founded
2015
Market Cap
870.19M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
689.88K
High Today
$23.06
Low Today
$22.06
Open Price
$22.66
Volume
173.29K
52 Week High
$29.32
52 Week Low
$12.67
Collections
Analyst Ratings
90%
of 10 ratings
Buy
90%
Hold
10%
Sell
0%
AVRO Earnings
-$2.98
-$1.99
-$0.99
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Mar 23, Pre-Market
People Also Bought
Viking Therapeutics
38,964
$6.89
-1.08%Corbus Pharmaceuticals
49,073
$5.57
-1.76%Hexo
166,615
$1.42
-1.51%Aurora Cannabis
671,428
$1.65
-1.79%CannTrust
103,242
$0.8162
-2.90%NIO
127,918
$4.06
-4.81%ImmunoGen
17,698
$5.39
-3.41%Beyond Meat
60,078
$117.13
-2.86%Verastem
17,519
$2.18
+3.81%Plug Power
211,401
$5.51
-0.06%Moderna
11,316
$18.11
-2.35%TG Therapeutics
5,251